Showing results (1421-1430 of 5,702) with videos related to
Sort By:
Pageof 571
The Oncologist|February 1, 2011
A new look at node-negative breast cancerNadia Harbeck, Christoph ThomssenThe Oncologist|November 3, 2010
Optimal sequence of implied modalities in the adjuvant setting of breast cancer treatment: an update on issues to considerPelagia G Tsoutsou, Yazid Belkacemi, Joseph Gligorov, et al.The Oncologist|January 8, 2011
Effect of exercise training on peak oxygen consumption in patients with cancer: a meta-analysisLee W Jones, Yuanyuan Liang, Edith N Pituskin, et al.The Oncologist|January 8, 2011
U.S. Food and drug administration approval: rituximab in combination with fludarabine and cyclophosphamide for the treatment of patients with chronic lymphocytic leukemiaSandra J Casak, Steven J Lemery, Yuan Li Shen, et al.The Oncologist|January 8, 2011
Current and emerging therapies for advanced adrenocortical carcinomaLyndal J Tacon, Ruth S Prichard, Patsy S H Soon, et al.The Oncologist|December 15, 2010
Corticosteroid use in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN studyJames J Vredenburgh, Timothy Cloughesy, Meghna Samant, et al.The Oncologist|December 15, 2010
The utility of BRAF testing in the management of papillary thyroid cancerAdrienne L Melck, Linwah Yip, Sally E CartyThe Oncologist|December 15, 2010
A Cancer and Leukemia Group B phase II study of sunitinib malate in patients with previously treated metastatic pancreatic adenocarcinoma (CALGB 80603)Eileen M O'Reilly, Donna Niedzwiecki, Margaret Hall, et al.The Oncologist|December 15, 2010
Approval summary: erlotinib maintenance therapy of advanced/metastatic non-small cell lung cancer (NSCLC)Martin H Cohen, John R Johnson, Somesh Chattopadhyay, et al.The Oncologist|December 1, 2010
The etiology of hepatocellular carcinoma and consequences for treatmentArun J Sanyal, Seung Kew Yoon, Riccardo LencioniPageof 571